HeartGPS for Mothers of Infants With Heart Defects

This trial aims to support mothers of infants diagnosed with congenital heart defects (CHD) by adding a new program called HeartGPS to their usual care. HeartGPS includes online counseling sessions, personalized educational resources, and a mental health care plan to help mothers navigate the emotional and practical challenges of having a baby with CHD. The study compares the outcomes of mothers receiving only standard care with those who also receive the HeartGPS program. Pregnant individuals carrying a fetus diagnosed with CHD, who plan surgery or intervention within the first month after birth, may be eligible to participate.

As an unphased trial, this study offers a unique opportunity to access additional support and resources that could significantly improve participants' experiences and outcomes.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that HeartGPS, a psychological program, helps mothers of babies with heart problems manage stress and anxiety. Specific safety information on HeartGPS is limited because it is a new type of psychological treatment, not a drug or medical device. However, studies on similar programs often find them safe and low-risk, as they focus on counseling and support.

Researchers are excited about HeartGPS for moms of infants with heart defects because it offers a comprehensive support system that goes beyond traditional care. Unlike standard care, which mainly focuses on the medical needs of the infant, HeartGPS combines emotional support, tailored education, and mental health planning specifically for the parents. This approach aims to guide parents through the emotional challenges, provide tailored information, and strengthen family connections, which can be crucial for overall family well-being. By targeting the parents' needs, HeartGPS hopes to improve the family's ability to manage their child's condition more effectively.

Research has shown that HeartGPS, a new psychological program tested in this trial, helps reduce stress and anxiety in mothers of babies with congenital heart defects (CHD). Participants in this trial may receive the HeartGPS intervention, which includes virtual counseling sessions and educational materials tailored for these mothers. Early results suggest that virtual technology and a simple design can help mothers manage their emotions and improve their mental health. Although the data is still developing, the program aims to support mothers by helping them handle emotional challenges, providing important information, and strengthening their support networks.²³⁶⁷⁸